Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study

This study has been completed.

Study NCT00216593 Information provided by Janssen Pharmaceutica N.V., Belgium

First Received: September 13, 2005 Last Updated: June 7, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2008
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)